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Abstract
Background: Mycobacteriophage Ms6 integrates into Mycobacterium smegmatis and M. bovis BCG
chromosome at the 3' end of tRNAala genes. Homologous recombination occurs between the phage attP
core and the attB site located in the T-loop. Integration-proficient vectors derived from Ms6 are useful
genetic tools, but their insertion sites in the BCG chromosome remain poorly defined. The primary
objective of this study was to identify Ms6 target genes in M. smegmatis and BCG. We then aimed to modify
the attP site in Ms6-derived vectors, to switch integration to other tRNAala loci. This provided the basis
for the development of recombinant M. bovis BCG strains expressing several reporter genes inserted into
different tRNAala genes.
Results: The three tRNAala genes are highly conserved in M. smegmatis and BCG. However, in the T-loop
of tRNAalaU and tRNAalaV containing the attB site, a single base difference was observed between the two
species. We observed that the tRNAalaU gene was the only site into which Ms6-derived integration-
proficient vectors integrated in M. smegmatis, whereas in BCG, the tRNAalaV gene was used as the target.
No integration occurred in the BCG tRNAalaU T-loop, despite a difference of only one base from the 26-
base Ms6 attP core. We mutated the attP core to give a perfect match with the other tRNAala T-loops from
M. smegmatis and BCG. Modification of the seven-base T-loop decreased integration efficiency, identifying
this site as a possible site of strand exchange. Finally, two Ms6 vectors were constructed to integrate two
reporter genes into the tRNAalaU and tRNAalaV T-loops of the same BCG chromosome.
Conclusion: Small changes in the 7 bp T-loop attP site of Ms6 made it possible to use another attB site,
albeit with a lower integration efficiency. These molecular studies on BCG tRNAala genes made it possible
to create valuable tools for the site-directed insertion of several genes in the same BCG strain. These tools
will be useful for the development of novel multivalent vaccines and genetic studies.
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Background
Temperate phages integrate into the bacterial chromo-
some through a site-specific recombination event cata-
lyzed by a phage-encoded recombinase. This process
involves a common core present in the phage attP and the
bacterial attB genomic DNA sequences, which are identi-
cal [1]. Genetic tools based on phage systems have fur-
thered research into the biology of Mycobacterium
tuberculosis, a pathogen responsible for about two million
deaths each year [2]. L5 [3] and Ms6 [4], both temperate
mycobacteriophages, integrate into genes encoding
tRNAs. L5 integrates into a tRNAgly gene in the genome of
the fast-growing species M. smegmatis or the slow-growing
species M. bovis Bacillus Calmette Guérin (BCG), which is
used as a vaccine against tuberculosis [5,6]. Integration-
proficient vectors containing the attP site and either a tyro-
sine-integrase [5,7] or a serine-integrase [8] system inte-
grate into the attB site of the mycobacterial chromosome.
Most of these integrative vectors do not retain recombina-
tion directionality factors from the phage that mediate
excision [9] and are generally stably maintained in the
mycobacterial genome, even in the absence of antibiotic
selection [10]. However, plasmid loss can occur through
low level integrase-mediated excision [11]. These vectors
are of considerable use both for the development of
recombinant BCG (rBCG) strains with long-term heterol-
ogous gene expression for vaccine development [10] and
for overcoming the problems associated with the use of
multicopy extrachromosomal plasmids in genetic studies.
Ms6-derived vectors integrate efficiently into the genomes
of both slow- and fast-growing mycobacteria. In M. smeg-
matis, the attB core site overlaps the 3' end of a tRNAala
gene containing the 7 bp T-loop [7]. The precise point of
strand exchange between attP and attB is unknown. In sil-
ico scanning of the genomes of M. smegmatis and M. tuber-
culosis showed that there were three tRNAala genes
containing 3' end attB sequences either identical or simi-
lar to the Ms6 attP core site. We show here that Ms6 inte-
grates into different tRNAala genes in M. smegmatis and
BCG, according to the presence of identical attB and attP
cores. We also used site-directed mutagenesis of the attP
core to construct vectors integrating into tRNAala genes
other than that targeted by the wild-type attP. This led to
the development of a method for integrating two vectors,
carrying different heterologous genes, into two different
loci of the same BCG chromosome.
Results
Genetic organisation of tRNAala genes from M. smegmatis 
and BCG
A BLASTn search of the M. tuberculosis genome [12] for
sequences similar to the Ms6 attP core region [13]
revealed three possible attB sites at the 3' ends of three
tRNAala genes, named after their anti codon: GGC for
tRNAalaU, CGC for tRNAalaV, and TGC for tRNAalaT. In
tRNAalaV, the attB core sequence was identical to the 26
bases of the attP core region [7]. In tRNAalaU and tRNAalaT,
one and three mismatches, respectively, were observed
between the 26 bp Ms6 attP and attB core sequences.
Alignment of the attP sequence with the genome of M.
bovis [14] revealed the presence of the same three attB sites
(data not shown). None of the tRNAalagenes mapped to
deletion regions described in BCG [15,16].
Alignment of the Ms6 attP core sequence with the genome
of M. smegmatis [17] revealed three possible attB sites dis-
playing sequence similarities. As for BCG, the three possi-
ble attB sites were located in tRNAalaU (anticodon GGC),
tRNAalaV (anticodon CGC) and tRNAalaT (anticodon TGC).
The three M. smegmatis and BCG tRNAala structures were
analysed with tRNA-scan SE [18]. A sequence identity
block common to attP-attB was identified that encom-
passed the tRNAala T-loop located at the 3' end, without
extending to the variable region (see additional file 2).
In both species, the tRNAala-encoding genes mapped to
distant regions of the chromosome. The three tRNAala
genes of M. smegmatis and BCG were highly similar, but
not identical. Interestingly, the tRNAalaV T-loop from BCG
was identical to the tRNAalaU T-loop from M. smegmatis. In
both species, the T-loop from two other tRNAala genes dif-
fered from the 26 bp core attP site from Ms6 by one to four
bases (Fig. 1A)
The integration of Ms6-derived vectors requires 100% 
identity of the 26 base cores of attP and attB
We have previously described the construction of pAV-
SIV, an Ms6-derived integration-proficient vector, for the
production of rBCG candidate vaccines genetically stable
in vivo and expressing genes from the simian immunode-
ficiency virus SIVmac251 [10]. Here, we analysed the
insertion locus of pAV-SIV in the BCG chromosome. We
carried out Southern blot analysis on genomic DNA using
a probe (see additional file 1 for all primers plasmids and
strains used in this study) designed from the tRNAalaU
gene from M. tuberculosis, as we previously showed that
the target insertion sequence corresponded to tRNAalaU
[7]. However, we did observe no band disruption when
the genomic DNA hybridisation profiles of pAV-SIV inte-
grants and wild-type BCG were compared, indicating that
the integration-proficient plasmids had not inserted into
the tRNAalaU gene (Fig. 1B, left panel). We then amplified
another probe derived from the tRNAalaV sequence and
observed, on a Southern blot of DNA from wild-type
BCG, two specific bands : a 9 kb band showing a strong
positive signal and a weakly hybridizing 7 kb band (Fig.
1B, right panel). Following transformation with pAV-SIV,
the 9 kb band disappeared, giving rise to two bands of 8
and 2 kb. The 7 kb band, due to cross-hybridisation of
tRNAalaU attB with the tRNAalaV probe, remained intact.
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This confirmed the specific integration of pAV-SIV into
the tRNAalaV gene displaying identity with the attP rather
than into the attB site from tRNAalaU, which has a base
mismatch. We then investigated whether Ms6-derived
vectors also targeted the M. smegmatis attB site displaying
100% identity with the Ms6 attP core – the tRNAalaU gene.
A Southern blot analysis with two probes containing
either the tRNAalaU or the tRNAalaV gene sequence revealed
that the 3 kb band hybridising with the tRNAalaU probe in
genomic DNA from wild-type M. smegmatis was disrupted
in DNA from pAV-SIV integrants, giving 2.5 kb and 1.3 kb
bands (Fig. 1C, left panel). When DNA was probed with
tRNAalaV, no difference in hybridisation profile was
observed between the wild type and integrants, demon-
strating an absence of integration into the tRNAalaV locus
(Fig. 1C, right panel).
We investigated whether integration into an attB site car-
rying mismatches with the attP core site was possible, as
reported for L5 [5], by designing three primer pairs to
amplify tRNAalaU, tRNAalaV or tRNAalaT regions both from
M. smegmatis and BCG genome sequences. The PCR
Southern blot of genomic DNA from wild-type and pAV6950-transfected M. bovis BCG and M. smegmatis integrantsFigur  1
Southern blot of genomic DNA from wild-type and pAV6950-transfected M. bovis BCG and M. smegmatis inte-
grants. A: Alignment between the three tRNAala gene sequences from M. bovis BCG or M. smegmatis and the Ms6 attP 26-base 
core sequence. The coloured blocks represent identical sequence stretches, base differences are indicated in bold and the anti-
codon is underlined. The position of anticodon and T-loops in the tRNAala sequence is indicated. B: Genomic DNA from wild-
type BCG (lane 1) and a pAV-SIV integrant (lane 2) was probed with a PCR product based on the tRNAalaU (left panel) or 
tRNAalaV (right panel) sequence from the M. tuberculosis genome. C: Genomic DNA from wild-type M. smegmatis (lane 1) and a 
pAV-SIV integrant (lane 2) was probed with a PCR product based on the tRNAalaU (left panel) or tRNAalaV (right panel) 
sequence from the M. smegmatis genome.
M. bovis BCG M. smegmatis
tRNAalaU tRNAalaV tRNAalaU tRNAalaV
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A                              26bp core attP                           Mismatches
                                         AGGGGTTCGAATCCCCTTAGCTCCAC                      attP-attB
5’
GGGGCTATGGCGCAGCTGGTAGCGCACCACACTGGCAGTGTGGGGGTC AGGGGTTCGAGTCCCCTTAGCTCCAC     tRNAalaU BCG         One
GGGGCTATGGCGCAGTTGGTAGCGCACCACACTGGCAGTGTGGGGGTC AGGGGTTCGAATCCCCTTAGCTCCAC     tRNAalaU M. smeg.    None
GGGGCTATGGCGCAGTTGGTAGCGCGACTCGTTCGCATCGAGTAGGTC AGGGGTTCGAATCCCCTTAGCTCCAC     tRNAalaV BCG         None
GGGGCTATGGCGCAGTTGGTAGCGCGACTCGTTCGCATCGAGTAGGTC AGGGGTTCGATTCCCCTTAGCTCCAC     tRNAalaV M. smeg.    One
GGGGCCTTAGCTCAGTTGGTAGAGCACTGCCTTTGCAAGGCAGGGGTC AGGGGTTCGAGTCCCCT-AGGCTCCAC     tRNAalaT BCG        Three
GGGGCCTTAGCTCAGTTGGTAGAGCGCTGCCTTTGCAAGGCAGATGTC AGGAGTTCGAATCTCCT-AGGCTCCAC     tRNAalaT M. smeg.   Four
D-loop A-loop T-loop
1.6
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amplification of genomic DNA from fifty pAV-SIV BCG
integrants identified tRNAalaV as the only gene target for
Ms6 integration. By contrast, in the 50 M. smegmatis inte-
grants analysed, pAV-SIV had inserted into the tRNAalaU
gene (data not shown).
Modification of the attP core makes integration into the 
T-loop of other tRNAala genes possible
The tRNAalaU gene (anticodon GGC) of BCG and the
tRNAalaV gene of M. smegmatis (anticodon CGC) differ
from the attP core by one base in the T-loop, whereas the
tRNAalaT genes differ from this core sequence by three and
four bases, respectively (Fig. 1A). We then investigated
whether modification of the attP site to match these T-
loops would allow us to target Ms6-derived integrative
vectors to other tRNAala genes. Site-directed mutagenesis
was performed on pAV6950, carrying the natural Ms6 attP
core sequence, to construct four vectors carrying modified
26 bp attP cores identical to the various tRNAala T-loops.
In M. smegmatis, the integration efficiency of pSV, carrying
an attP core identical to the tRNAalaV T-loop, was only 12%
that of the non-mutated pAV6950 targeting tRNAalaU
(Table 1). PCR amplification of M. smegmatis pSV inte-
grants confirmed that the vector had targeted tRNAalaV in
all clones, as expected. When four base changes were
introduced, to match the tRNAalaT T-loop sequence (plas-
mid pST), integration efficiency was only 0.05% that with
the non-mutated pAV6950.
In BCG, pBU, in which the sequence TTCGAA was
mutated to TTCGAG to match the tRNAalaU T-loop, inte-
gration efficiency was 34% that for the non-mutated
pAV6950 targeting tRNAalaV (Table 1). In all integrants,
pBU targeted the tRNAalaU T-loop, as expected. When three
base changes were introduced, to match the tRNAalaT T-
loop, integration efficiency was 18% with respect to the
non-mutated attP. In all clones tested, integration into
tRNAalaT had occurred.
Ms6-derived vectors targeting two different tRNAala T-
loops in BCG can be used to construct bivalent 
recombinant BCG strains
As pBU made possible integration into tRNAalaU, we inves-
tigated whether both tRNAalaU and tRNAalaV could be tar-
geted in the same BCG strain. BCG was electroporated
with pNIP46, a pAV6950-derived vector (targeting the
tRNAalaV T-loop in BCG) containing the SIVmac251
gagp26 gene and a gene conferring resistance to hygromy-
cin. The recombinant BCG::pNIP46 strain expressing
gagp26 was then transformed with pBU-lacZ, containing
the Escherichia coli lacZ and a kanamycin resistance gene.
Recombinant clones, selected on medium supplemented
with kanamycin and X-gal, displayed β-galactosidase
activity (Fig. 2A). The expression of gagp26 was also
detected in these clones by western blotting (Fig. 2B). PCR
was used to determine the site of integration of the various
plasmids in the BCG integrants (Fig. 2C). It was found
that pNIP46 had inserted into tRNAalaV and pBU-lacZ into
tRNAalaU. In the double integrant, BCG::pNIP46::pBU-
lacZ, both tRNAalaU and tRNAalaV were disrupted. A dia-
gram of this double integration of an Ms6-derived vector
carrying natural attP in BCG tRNAalaV and an Ms6-derived
vector with modified attP in BCG tRNAalaU is provided in
Figure 2D.
Discussion
Determination of the complete genome sequences of M.
tuberculosis [12] and M. smegmatis [17] made it possibe to
analyse the possible integration targets of Ms6-derived
vectors. In contrast to expectations [7], we observed that
Ms6 targeted two different tRNAala genes in the fast-grow-
ing species M. smegmatis and the slow-growing species M.
bovis BCG. The critical factor defining the exclusive inte-
gration site was the presence in the attB region of a core
sequence identical to that of Ms6 attP. Thus, whereas in M.
smegmatis 100% of the transformants obtained with Ms6-
derived integration-proficient vectors displayed insertion
into tRNAalaU, in BCG, all transformants carried the vector
in tRNAalaV. In the case of L5, another temperate mycobac-
teriophage widely used for genetic studies [3], integration
Table 1: Integration efficiency of vectors carrying attP core modifications
Vector 26 bp core attPa Integration efficiency/
pAV6950b
% integration into the tRNAala T-loopc
M. smegmatis M. bovis BCG M. smegmatis M. bovis BCG
pAV6950 AGGGGTTCGAATCCCCTTAGCTCCAC 100% 100% 100% in tRNAalaU 100% in tRNAalaV
pBU AGGGGTTCGAGTCCCCTTAGCTCCAC 1.1% 34% ND 100% in alaU
pBT AGGGGTTCGAGTCCCCTAGGCTCCAC 0.7% 18% ND 100% in tRNAalaT
pSV AGGGGTTCGATTCCCCTTAGCTCCAC 12% 0.8% 100% tRNAalaV ND
pST AGGAGTTCGAATCTCCTAGGCTCCAC 0.05% ND ND ND
a: Changes introduced by site-directed mutagenesis, with respect to the original attP site from pAV6950 are indicated in bold
b: Identical amounts of plasmid DNA were used to electroporate competent M. smegmatis or BCG. Integrants were numbered and the percentage 
of [integrants with modified attP/integrants with pAV6950] was calculated.
c: The insertion locus was determined by PCR amplification and the percentage of clones in the given tRNAala T-loop was calculated
BMC Molecular Biology 2006, 7:47 http://www.biomedcentral.com/1471-2199/7/47
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into the attB site of the BCG chromosome may occur in a
tRNAglyV gene carrying one mismatch with the attP mini-
mal core [5]. However, analysis of the three tRNAgly genes
of BCG showed that there was no tRNAgly carrying an attB
sequence identical to L5 attP in BCG (data not shown).
L5-derived vectors therefore target an attB sequence carry-
ing one mismatch with attP. This mismatch does not seem
to affect the efficiency of L5 integration in BCG [5]. How-
Bivalent recombinant BCG strain containing two pAV6950-derived vectors inserted into the tRNAalaU and tRNAalaV T-loopsF gure 2
Bivalent recombinant BCG strain containing two pAV6950-derived vectors inserted into the tRNAalaU and 
tRNAalaV T-loops. BCG was transformed with the two vectors – pNIP46, targeting tRNAalaV, and pBU-lacZ, targeting 
tRNAalaU – to obtain a strain coexpressing the two foreign genes. A: Expression of the lacZ gene in rBCG::pNIP46::pBU-lacZ 
was detected as blue coloration on agar plates supplemented with the β-galactosidase substrate X-gal. B: Expression of gagp26 
was detected by western blotting and wild-type BCG (lane 1), rBCG::pNIP46, (lane 2) and three different clones of 
rBCG::pNIP46::pBU-lacZ (lanes 3, 4, 5) were analysed. Lane 6 corresponds to purified recombinant Gagp26 produced in E. coli 
with an N-terminal His-tag. C: Multiplex PCR using the three sets of primers located upstream and downstream from the 
three different attB sites in BCG. Absence of the 200 bp, 400 bp or 600 bp amplification products indicates disruption of the 
tRNAalaU, tRNAalaV and tRNAalaT T-loops, respectively. The three fragments were present in the wild-type BCG chromosome 
(lane 1). After a single integration of pBU-lacZ into tRNAalaU, only the 600 and 400 bp fragments were present (lane 2), and in 
BCG::pNIP46, in which tRNAalaV had been disrupted, both the 600 and 200 bp fragments were amplified (lane 3). pBT disrupted 
the tRNAalaT locus (lane 4). In the double integrant, BCG::pNIP46::pBU-lacZ, only the tRNAalaT locus was intact and gave the 
600 bp amplification fragment (lane 5). D Integration of each vector was confirmed by PCR using a mixture of the three prim-
ers upstream from tRNAalaU, tRNAalaV and tRNAalaT combined with LM2, annealing to the Ms6 integrase. No amplification was 
detected in wild type BCG chromosome (lane 1), by contrast, single products were detected in BCG::pBU-lacZ (lane 2), 
BCG::pNIP46 (lane 3) and BCG::pBT (lane 4). In BCG::pNIP46::pBU-lacZ two bands were obtained confirming the double inte-
gration (lane 5). E A diagram of the double integration of pNIP46 and pBU-lacZ is provided
A
E
attB tRNAalaV attBlike tRNAalaU
pBU
pBlaF*-lacZ
LacZ
aph
attPmut
pNIP46
pBlaF*-gag
gag
hygB
attP
BCG 1173P2
hygB aphBCG::pNIP46::pBULacZ
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Ms6 derived 
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D
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ever, this mismatch maps outside the tRNAglyV 7 bp anti-
codon loop in which strand exchange beween attP and
attB occurs [6].
The three tRNAala gene sequences displayed a high degree
of similarity between M. smegmatis and BCG. Only two
base differences in tRNAalaU and one base difference in
tRNAalaV were observed. Interestingly, whereas the first 25
bases of the tRNAalaU and tRNAalaV anticodon loops were
identical, the nucleotides involved in the formation of
anticodon loop flanking symmetry differed in the
tRNAalaU and tRNAalaV genes. This may be a signature of
ancestral recombination between the tRNAala genes dur-
ing evolution. The T-loops were remarkably conserved
between tRNAalaU and tRNAalaV and between the species.
However, one base difference occurred in this region con-
taining the attB site. Point mutations occurring separately
in the two species during evolution may account for these
observations. Alternatively, the Ms6 phage or its ancestors
may have introduced some of these mutations, as myco-
bacteriophages have actively participated in remodelling
of the bacterial chromosome [19].
We next investigated whether the two "attB-like"
sequences located in the two other tRNAala T-loops were
potential target sites for modified Ms6. Indeed, with an
integrase trained on one gene, a small change in the attP
sequence may allow the element to switch to another
tRNAala gene. We therefore mutated the 26-base attP core
and assessed integration into the other mycobacterial loci.
In BCG, one base difference between natural attP (TTC-
GAA) and pBU attP-like (TTCGAG) sequences reduced
integration efficiency by 70%, despite identity with attB
(tRNAalaU). The mutation introduced in attP was located
in the 7 bp identical to the T-loop of the tRNAala gene but
did not directly affect flanking symmetry (for review [1].
This change, although minor in nature, caused a dramatic
drop in integration efficiency. Two additional changes in
the 26-base sequence (pBT) only slightly reduced integra-
tion efficiency further in BCG, from the 70% decrease
with pBU (one base change) to an 80% decrease with pBT
(three base changes). This identifies the 7 bp T-loop
sequence TTCGAA as important for Ms6 integration.
Indeed, when M. smegmatis was electroporated with pBU
(TTCGAG), despite there being only one base difference
between this mutated attP and the three attB sites availa-
ble in the genome, very few integrants were obtained
(99% decrease in efficiency). Phages have been classified
according to integration site sublocation within tRNA or
tmRNA genes [20]. Class I phage integrase targets the
tRNA anticodon loop whereas class II targets the tRNA T-
loop. The precise crossover segment has been examined in
class I phages, in which it maps to the 7 bp anticodon-
encoding loop. This is also the case for mycobacteri-
ophage L5 [6], which belongs to class I [20]. The precise
location for crossover in class II phages remains
unknown. Our data suggest that strand exchange between
the class II phage Ms6 attP and mycobacterial attB occurs
precisely in the 7 bp T-loop from tRNAala.
Integration-proficient vectors derived from the temperate
mycobacteriophage Ms6 are particularly useful for con-
structing recombinant BCG strains that are genetically sta-
ble in vivo [10]. BCG is also of considerable interest for use
in the development of vaccines for simultaneous immuni-
sation against several pathogens. The next step was to use
Ms6 integration-proficient vectors targeting different
tRNAala T-loops in BCG to construct multivalent vaccine
strains. We therefore constructed one vector carrying the
natural attP core (TTCGAA/tRNAalaV), a SIVmac251 gene
encoding Gagp26 and another carrying an attP site target-
ing tRNAalaU (TTCGAG) and carrying the lacZ gene from E.
coli. In the rBCG::pNIP46::pBU-lacZ strain transformed
with the two vectors, we observed expression of both the
gagp26 and lacZ genes. Interestingly, the level of expres-
sion of gagp26 in the bivalent strain was similar to that
observed in the monovalent rBCG::pNIP46 strain. This
method may therefore be useful for the future develop-
ment of new rBCG vaccines carrying multiple heterolo-
gous genes that will help in immunisation programmes.
Methods
Bacterial strains and plasmids
The E. coli, M. smegmatis, M. bovis BCG strains and the
plasmids and primers used in this study are described in
additional file 1. Mycobacterial strains were electropo-
rated as previously described [21]. The plasmid pAV-SIV
[10] was derived from pAV6950 [7], containing the attP-
int region from mycobacteriophage Ms6 and an origin of
replication from E. coli. It contains SIVmac251 genes
inserted into the single EcoRI site of pAV6950 located
upstream from the attP core and int gene. Similarly, pBU-
lacZ contains the gene encoding β-galactosidase from E.
coli inserted upstream from the modified attP core. Both
pAV-SIV and pBU-lacZ express the aph3' gene from Tn5,
conferring resistance to kanamycin (20 µg ml-1). pNIP46
is a pAV6950 derivative containing the hygB gene from
Streptomyces hygrospicus conferring resistance to hygromy-
cin (50 µg ml-1) and the gagp26 gene from SIVmac251.
BCG transformants were selected on solidified Middle-
brook 7H11 medium (Difco) supplemented with OADC
(0.05% oleic acid, 5% bovine serum albumin fraction V,
2% dextrose, 0.004% beef catalase, 0.85% NaCl) and the
appropriate antibiotic. β-galactosidase activity in BCG
transformed with pBU-lacZ was visualised by adding X-gal
(80 µg ml-1, MP Biomedicals, Inc.) to the medium.
PCR, Southern blotting and site-directed mutagenesis
PCR was performed in a final volume of 50 µl containing
chromosomal DNA, 1.5 mM MgCl2, 200 µM of each
BMC Molecular Biology 2006, 7:47 http://www.biomedcentral.com/1471-2199/7/47
Page 7 of 8
(page number not for citation purposes)
dNTP, 50 pmoles of each primer and 1 unit of polymer-
ase. Thirty-five cycles of [94°C 30 seconds, 60°C 30 sec-
onds, 72°C 90 seconds] were run. For Southern blot
analysis, genomic DNA from BCG and M. smegmatis pAV-
SIV integrants was digested with BamHI for 18 hours at
37°C. Probes were generated by PCR amplification (see
primers in Table 1), using M. tuberculosis cosmid 22D7 for
tRNAalaU or cosmid 237 for tRNAalaV or genomic M. smeg-
matis DNA. For site-directed mutagenesis of the attP core
site, the QuickChange™ Site-Directed Mutagenesis kit
from Stratagene (La Jolla, CA) was used according to the
manufacturer's instructions. This procedure uses double-
stranded DNA and two primers complementary to oppo-
site strands of the vector and each containing the desired
mutation. For site-directed mutagenesis, only the
sequence primers identical to the attP core site are listed in
additional file 1. Both this primer and the complementary
primer were used in the reaction.
Western blotting
Recombinant BCG colonies were grown at 37°C in Mid-
dlebrook 7H9 (Difco) medium supplemented with 10%
ADC (5% bovine serum albumin fraction V, 2% dextrose,
0.003% beef catalase) and 0.05% Tween 80. We evaluated
gagp26 expression with total protein extracts prepared as
previously described [21]. Gagp26 was detected by incu-
bation with a 1:500 dilution of polyclonal rabbit anti-Gag
antibody followed by a 1:10000 dilution of anti-rabbit
peroxidase-conjugated IgG (Amersham) and visualisation
with an enhanced chemiluminescence kit (Amersham).
Abbreviations
BCG: Bacillus Calmette-Guérin; rBCG: recombinant BCG;
SIV: simian immunodeficiency virus.
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